Ipidacrine information

Ipidacrine
Clinical data
Trade names	Neiromidin
Other names	Amiridine; NIK-247
ATC code	N06DA05 (WHO) ;
Legal status
Legal status	US: Unscheduled Not FDA approved;
Identifiers
	IUPAC name 2,3,5,6,7,8-Hexahydro-1H-cyclopenta[b]quinolin-9-amine;
CAS Number	62732-44-9;
PubChem CID	604519;
ChemSpider	525510;
UNII	CV71VTP0VN;
ChEMBL	ChEMBL130880;
CompTox Dashboard (EPA)	DTXSID7048299 ;
ECHA InfoCard	100.201.385
Chemical and physical data
Formula	C12H16N2
Molar mass	188.274 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES C1CCc2c(c(c3c(n2)CCC3)N)C1;
	InChI InChI=1S/C12H16N2/c13-12-8-4-1-2-6-10(8)14-11-7-3-5-9(11)12/h1-7H2,(H2,13,14); Key:YLUSMKAJIQOXPV-UHFFFAOYSA-N;

Ipidacrine (Neiromidin) is a drug first synthesized by the National Research Center for Biologically Active Compounds in the Russian Federation. This compound is a modification of the older drug tacrine (Cognex).^[1]

Ipidacrine is a reversible acetylcholinesterase inhibitor used in memory disorders of different origins.^[2]^[3]^[4]

Ipidacrine directly stimulates impulse transmission in the central nervous system and neuromuscular synapses by blocking membrane potassium channels. Ipidacrine enhances not only choline, but also adrenaline, serotonin, histamine, and oxytocin effects on smooth muscle.^[5]

^ Kojima J, Onodera K, Ozeki M, Nakayarna K (1998). "Ipidacrine (NIK-247): A Review of Multiple Mechanisms as an Antidementia Agent". CNS Drug Reviews. 4 (3): 247–259. doi:10.1111/j.1527-3458.1998.tb00067.x.
^ Damulin IV, Stepkina DA, Lokshina AB (2011). "[Neuromidin in mixed vascular and Alzheimer's dementia]". Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova. 111 (2): 40–3. PMID 21350422.
^ Pustokhanova LV, Morozova EM (2011). "[Cognitive disorders in the early rehabilitation period of ischemic stroke and possibilities of their treatment with neuromidin]". Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova. 111 (4 Pt 2): 23–7. PMID 23120773.
^ Onodera K, Kojima J, Wachi M (April 1998). "Ipidacrine (NIK-247), a novel antidementia, rapidly enters the brain and improves scopolamine-induced amnesia in rats during the Morris water maze task". Nihon Shinkei Seishin Yakurigaku Zasshi = Japanese Journal of Psychopharmacology. 18 (2): 33–7. PMID 9656230.
^ "Neiromidin Product Information". Archived from the original on 2013-06-13. Retrieved 2013-05-30.

[1] Kojima J, Onodera K, Ozeki M, Nakayarna K (1998). "Ipidacrine (NIK-247): A Review of Multiple Mechanisms as an Antidementia Agent". CNS Drug Reviews. 4 (3): 247–259. doi:10.1111/j.1527-3458.1998.tb00067.x.

[2] Damulin IV, Stepkina DA, Lokshina AB (2011). "[Neuromidin in mixed vascular and Alzheimer's dementia]". Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova. 111 (2): 40–3. PMID 21350422.

[3] Pustokhanova LV, Morozova EM (2011). "[Cognitive disorders in the early rehabilitation period of ischemic stroke and possibilities of their treatment with neuromidin]". Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova. 111 (4 Pt 2): 23–7. PMID 23120773.

[4] Onodera K, Kojima J, Wachi M (April 1998). "Ipidacrine (NIK-247), a novel antidementia, rapidly enters the brain and improves scopolamine-induced amnesia in rats during the Morris water maze task". Nihon Shinkei Seishin Yakurigaku Zasshi = Japanese Journal of Psychopharmacology. 18 (2): 33–7. PMID 9656230.

[5] "Neiromidin Product Information". Archived from the original on 2013-06-13. Retrieved 2013-05-30.

Ipidacrine information

and 23 Related for: Ipidacrine information

Ipidacrine

C12H16N2

Caffeine

ATC code N06

Tetrahydrocannabinol

Botulinum toxin

Sarin

Anticholinergic

Donepezil

Acetylcholine

Choline

Nerve agent

Novichok

Physostigmine

Itopride

Neostigmine

Acetylcholinesterase inhibitor

Rivastigmine

Malathion

Soman

Dichlorvos

Cholinergic

Galantamine